MEDTRONIC PUERTO RICO OPERATIONS CO. SYNCHROMED II; PUMP, INFUSION, IMPLANTED, PROGRAMMABLE
|
Back to Search Results |
|
Model Number 8637-40 |
Device Problems
Fluid/Blood Leak (1250); Improper Flow or Infusion (2954); Infusion or Flow Problem (2964); Material Integrity Problem (2978)
|
Patient Problem
Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
|
Event Date 05/17/2022 |
Event Type
Injury
|
Manufacturer Narrative
|
Concomitant medical products: product id: 8703w, lot#: l60552, implanted: (b)(6) 1999, product type: catheter.Other relevant device(s) are: product id: 8703w, serial/lot #: (b)(4), udi#: (b)(4).If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Information was received from multiple sources (manufacturer representative, healthcare provider) regarding a patient who was receiving unknown baclofen via an implantable pump for unknown indications for use.It was reported that the patient had a return of symptoms.There was no environmental/external/patient factors that may have led or contributed to the issue noted.A catheter dye study was performed and was unsuccessful.It was noted the hcp did not push dye through the catheter so was unable to determine catheter patency at that time.The issue was not resolved.
|
|
Manufacturer Narrative
|
The catheter was received for analysis on 2023-09-14.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information was received from the manufacturer representative (rep).It was reported that the patient was experiencing lessened effect of medication despite a dose increase.It was noted that the reason for catheter removal was a break/tear/hole.The catheter was replaced at the pump segment.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
Event Description
|
Additional information was received from a healthcare provider (hcp) via a manufacturer representative (rep) indicating that, upon refills, a volume discrepancy occurred.The patient was experiencing withdrawal symptoms.The patient's dose was increased.Per the patient, a dye study was performed and showed a catheter leak in the pump segment.A catheter replacement occurred on (b)(6) 2023.It was unknown if there were any environmental, external, or patient factors that may have led or contributed to the issue.The date that the event occurred was asked but was unknown.At the time of this report, it was unknown if the issue was resolved.The patient status was "alive-no injury".The patient's weight and medical history were asked but would not be made available.The pump was used to deliver unknown baclofen 2000mcg/ml at 885mcg/day.
|
|
Manufacturer Narrative
|
H3 ¿ analysis of the returned catheter segment found ¿no significant anomaly ¿ pump connector damaged at explant ¿ tearing seen consistent with suture removal ¿ area did not leak during pressure testing¿.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|